NAFLD, divided into two categories: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), is a group of diseases with different clinical manifestations and progression rates in individuals (116)
Black Box Warning : GLP-1 receptor agonists carry a warning regarding an increased risk of thyroid C-cell tumors
Semaglutide GLP-1 and Ozempic are essentially the same medication, with Ozempic being the brand name for semaglutide GLP-1
GLP-1 lawsuits involve allegations that manufacturers of medications such as Ozempic, Wegovy, Mounjaro, Zepbound, and related drugs failed to adequately warn consumers and prescribing physicians about serious health risks associated with these medications
Years passed
Pancreatitis and Pancreatic Cancer: Debates and lawsuits center around the drug potentially raising pancreatitis risks, with caution also regarding long-term pancreatic cancer risks, especially in those with additional risk factors